CAS 5531-98-6: 3,4-Dimethoxy-N,N-dimethyl-1-phenanthreneethanamine
Fórmula:C20H23NO2
InChI:InChI=1S/C20H23NO2/c1-21(2)12-11-15-13-18(22-3)20(23-4)19-16-8-6-5-7-14(16)9-10-17(15)19/h5-10,13H,11-12H2,1-4H3
Clave InChI:InChIKey=UZZFAUDNCIFFPM-UHFFFAOYSA-N
SMILES:O(C=1C=C(C=2C=CC=3C=CC=CC3C2C1OC)CCN(C)C)C
- Sinónimos:
- 1-Phenanthreneethylamine, 3,4-dimethoxy-N,N-dimethyl-
- 1-phenanthreneethanamine, 3,4-dimethoxy-N,N-dimethyl-
- 3,4-Dimethoxy-N,N-dimethyl-1-phenanthreneethanamine
- Atherosperminine
- NSC 93678
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Atherosperminine REF: 7W-GY8258CAS: 5531-98-6 | - - - | A consultar | Mar 04 Mar 25 |
 | Atherosperminine REF: BP-BP4380CAS: 5531-98-6 | 95%~99% | 166,00 €~466,00 € | Mar 04 Mar 25 |
 | Atherosperminine REF: TM-TN3466CAS: 5531-98-6 | 99.4% | 94,00 €~750,00 € | Lun 10 Mar 25 |
 | Atherosperminine REF: 3D-FAA53198CAS: 5531-98-6 | Min. 95% | A consultar | Lun 14 Abr 25 |
Ref: 7W-GY8258
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
Ref: BP-BP4380
| 5mg | 166,00 € | ||
| 10mg | 256,00 € | ||
| 20mg | 466,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
Atherosperminine
CAS:5531-98-6
Atherosperminine inhibits AChE/BChE and relaxes trachealis via cAMP phosphodiesterase inhibition.
Fórmula:
C20H23NO2
Pureza:
99.4%
Forma y color:
Solid
Peso molecular:
309.4
Ref: TM-TN3466
| 1mg | 94,00 € | ||
| 2mg | 140,00 € | ||
| 5mg | 208,00 € | ||
| 10mg | 313,00 € | ||
| 25mg | 533,00 € | ||
| 50mg | 750,00 € | ||
| 1mL*10mM (DMSO) | 210,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
Atherosperminine
Producto controladoCAS:5531-98-6
Atherosperminine is a hydroxylated derivative of forskolin. It can be converted to forskolin by the …
Fórmula:
C20H23NO2
Pureza:
Min. 95%
Peso molecular:
309.4 g/mol
Ref: 3D-FAA53198
| 25mg | 1.034,00 € | ||
| 50mg | 1.354,00 € | ||
| 100mg | 2.166,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025
